Viatris is focused on making high quality medicines available to everyone who needs them. We, globally, offer robust portfolio of more than 7,500 products, including generics and brand. Viatris markets products in more than 165 countries and territories. Our customers include consumers, retail and pharmacy establishments, wholesalers, governments, institutions and physicians.
Ensuring Quality and Safety are Our Highest Priorities
We know that what we do directly impacts the health and well-being of patients. As a result, protecting patients and consumer health by ensuring the quality and safety of our products is at the heart of how we operate across our network. From product development to making or sourcing raw materials to producing finished dosage forms, every step of our development, manufacturing and monitoring processes is grounded in this commitment.
We employ a team of highly-trained scientists and technical professionals with extensive experience in the pharmaceutical industry to develop each product formulation and to identify the specific processes and technologies used to manufacture our products. All our applications are subject to a robust regulatory review before a product can be brought to market. We monitor the performance of our products after approval and identify and implement any changes necessary to ensure quality. Significant changes also are subject to review by regulatory agencies.